摘要
18 例带配子体的恶性疟患者随机分为2 组: 双氢青蒿素组10 例, 口服5 d 疗程总量360 mg ; 奎宁组8 例, 口服7 d 疗程总量10 500 mg 。全部患者每天涂血片计算配子体密度, 于给药当天(D0) , 药后4 、7 、10 、14 、21 和28 d (D4 、D7 、D10 、D14 、D21 、和D28) 取血作大劣按蚊感染试验。患者血中配子体转阴时间, 双氢青蒿素组为21 .8 ±5 .2 d ; 奎宁组为31 .5 ±8 .7 d 。按蚊感染试验结果: 双氢青蒿素组有4 例在D0D4 、D7 、D10 、D14 均未能感染按蚊; 其余6 例于D0 、D4 、D7 、D10 、D14 、D21 按蚊感染阳性例数为6/6 、6/6 、6/6 、2/6 、0/6 和0/6 。奎宁组D0 、D4 、D7 、D10 、D14 、D21 和D28 按蚊感染阳性例数为4/8 、8/8 、8/8 、8/8 、8/8 、2/8 和0/8 。这表明双氢青蒿素5 d 总量360 mg 对恶性疟原虫有性生殖期发育有明显抑制作用, 对生理上未成熟的配子体, 可中断其发育。
Eighteen falciparumn malaria patients with gametocytemia were randomly allocated to 2 groups,treated respectively with dihydroartemisinin (DATM) tablets at a total dose of 360 mg over 5 days and with oral quinine sulfate (QN) at a total dose of 10 5000 mg over 7 days. Peripheral gametocyte counts were done daily in all patients until its disappearance. Blood samples were taken on D0, D4, D7, D10, D14, D21 and D28 from the patients to perform infectivity tests to Anopheles dirus. The result showed that the mean clearance times of PFG were 21.8±5.2 days in DATM group and 31.5±8.7 days in QN group respectively. And in DATM group, the infectivity tests were positive in 6 cases only. In those 6 positive cases, the numbers of the positive infectivity on D4, D7, D10, D14 and D21 were 6/6,6/6,2/6,0/6 and 0/6 respectively. While the 4 negative cases on D0 remained negative infectivity on D4, D7, D10, D14. In QN group, the infectivity tests were positive in 4 cases too on D0, the numbers of positive cases on D4, D7, D10, D14, D21 and D28 were 8/8,8/8,8/8,8/8,2/8 and 0/8 respectively. These indicate that QN cannot inhibit P.Falciparum at sexual stage, while DATM has a remarkable inhibitory effect, and may prevent the immatured PFG that was failure to infect An. dirus on D0 from maturing.
出处
《中药新药与临床药理》
CAS
CSCD
1999年第6期333-335,共3页
Traditional Chinese Drug Research and Clinical Pharmacology
基金
卫生部科研基金!(94-2 -069)
国家中医药管理局科研基金!(95B128)
广东省自然科学基金!(90043)
关键词
青蒿素
青蒿琥酯
治疗应用
疟疾
药物疗法
Artemisinin/ther. use
@ Artesunate/ther. use
Malaria, falciparum/TCD therapy
Plasmodium falciparum/drug eff
@ Artemisinin/analogs and derivatives (original article on page 333)